Current View from Alzheimer Disease to Type 2 Diabetes Mellitus
Mahmood Rasool, Arif Malik, Aamer M. Qazi, Ishfaq A. Sheikh, Abdul Manan, Sumaira Shaheen, Mahmood H. Qazi, Adeel G. Chaudhary, Adel M. Abuzenadah, Muhammad Asif, Mohammed H. Alqahtani, Zafar Iqbal, Munvar M. Shaik, Siew H. Gan and Mohammad A. Kamal
Affiliation: Center of Excellence in Genomic Medicine Research, Post Box No. 80216, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Keywords: Neurodegenerative, type 2 diabetes mellitus, pancreatic cells, amyloid.
Alzheimer’s disease (AD) is a neurodegenerative disorder that leads to memory problems. It has been
associated with type 2 diabetes mellitus at both the molecular and biochemical level. Pancreatic cells have molecular
similarities to the brain at the transcriptomic and proteomic levels. Several genes have been reported to be responsible for
both AD and diabetes. Currently, no proper treatment is available but various therapeutic approaches are utilized
worldwide for the management of these disorders and may be nanoparticles and herbal treatment of Bacopa monnieri will
make promise for the treatment of AD in future. The formation of amyloids in neurons and the formation of amylin in
pancreatic cells are potential links between these two disorders, which can be silent killers.
Rights & PermissionsPrintExport